Home / Shop / Growth-Factor Research / Tesamorelin
Tesamorelin research vial
Growth-Factor Research

Tesamorelin

Tesamorelin is a stabilised synthetic analogue of growth-hormone-releasing hormone (GHRH), studied for its effects on the GH/IGF-1 axis and visceral-fat metabolism. Supplied lyophilised for laboratory research use only.

Read the full research profile →
How it works · what studies report · scientific references
In stock
≥99% purity target · lot-tracked
Select size
10 mg vial
€70.0010 mg vial
Ships from IrelandTracked, inside the EU
Dispatched in 1–2 working daysTracked, EU dispatch
Lost in transit?Replacement first
Real supportWhatsApp & email
Plain outer packaging, no product names or branding on the parcel. Questions? WhatsApp us
Secure guest checkout — pay by bank transfer.
Why does the vial look empty?
That’s normal. The peptide is supplied lyophilised (freeze-dried) — often a thin film or a few milligrams at the base of the vial, easy to mistake for empty. It’s all there; reconstitute with bacteriostatic water before use.
Research handling note
Reconstitute with bacteriostatic water and store the lyophilised vial at −20 °C until use; once reconstituted, refrigerate and use within the documented window. For laboratory research purposes only — not for human consumption, diagnostic, or therapeutic use. Need to work out your dilution? Use the reconstitution calculator →
Growth-Factor Research

Tesamorelin — research profile

For research purposes only — not for human consumption

Tesamorelin is a synthetic, stabilised analogue of growth-hormone-releasing hormone (GHRH). It is studied for its ability to stimulate the body’s own pulsatile release of growth hormone, acting one step upstream of the GH/IGF-1 axis.

It is the most clinically-characterised GHRH analogue, having been evaluated in controlled trials for the reduction of visceral adipose tissue, which is the main focus of metabolic-research interest.

How it’s studied

  • GHRH-receptor agonism: stimulation of endogenous GH pulses.
  • GH/IGF-1 axis: downstream insulin-like growth-factor signalling.
  • Visceral fat: lipolytic effects on abdominal adipose tissue.

Areas under investigation

AreaReported research focus
Visceral adiposityReduction of visceral fat in controlled cohorts.
GH/IGF-1 axisEndogenous GH release and IGF-1 response.
Metabolic profileLipid and body-composition pathways.

References

  1. Falutz J, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007;357(23):2359–2370.

Specifications

SpecificationDetail
ProductTesamorelin
FormatLyophilised vial
Fill10 mg per vial
Molecular formulaC221H366N72O67S
PuritySpecified to a 99%+ purity target — per-batch documentation will be published once independent lab testing completes
Price€70.00
AvailabilityIn stock — dispatched from Ireland within 1–2 working days, tracked
Supplied forLaboratory research use only — not for human consumption, diagnostic or therapeutic use

Related research reading

Neutral reference material and handling tools from across the site. Research use only.

Research

Growth-factor research peptides

GHRH analogues and growth-factor secretagogues studied in laboratory research.
Guide

Reconstitution & storage

The general laboratory handling procedure for lyophilised research peptides: diluents, storage temperatures and shelf-life.
Tool

Reconstitution calculator

Work out the exact bacteriostatic water to add and the volume to draw for a target research concentration.
Verifiability

Batch Testing & COA

Every production batch is sent for independent, third-party analysis at Janoshik Analytical. When results return, the full Certificate of Analysis for the exact batch you receive is published here and in our COA library, carrying its SHA-256 checksum and the lot number printed on your vial, so you can confirm the document is genuine and untampered. We publish every certificate, including any that fail.

How to verify a COA and its SHA-256 checksum →